SBIR/STTR Research Award
Funding of Phase II SBIR Contract. N44 DA-12-2227
Award amount
$997,491Program and phase
SBIR · Phase IIAward year
2013Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- AICURE, LLC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- VZBHVD36W5D5
- Solicitation number
- Not reported
- Topic code
- NIDA
Research abstract
Under this Small Business Innovation Research (SBIR) Phase II project, Automating Directly Observed Therapy as a Platform Technology, under Research Topic 139, the Contractor shall provide and evaluate the effectiveness and accuracy of a system for monitoring medication adherence in a treatment setting. In addition to monitoring, an intrinsic component of the system will be an integrated communication platform allowing for intervention and feedback with the user and a measure of the accuracy of the system. Following additional development work on the system, the Contractor will implement the AiView-HR system in a clinical trial with the objectives of (1) providing a measure of the accuracy of the system, and (2) demonstrating that the system improves medication adherence. PUBLIC HEALTH RELEVANCE
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Automating Directly Observed Therapy as a Platform Technology
- Fractal Identification System for Medication
- OTHER FUNCTIONS: SBIR PHASE I, MED. ADHERENCE IN HIGHER RISK POPULATIONS, N43DA-12-2227, BASE AWARD.
- Gesture Based Medication Adherence Confirmation for Clinical Trials
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Wearable Wireless Respiratory Monitoring System that Detects and Predicts Opioid Induced Respiratory Depression
- Building and testing the Life Enhancement and Advocacy Programming digital training tool (LEAPLink) to better serve people with lived experience of homelessness and substance use disorder
- A digital intervention to decrease self-stigma among pregnant and postpartum women with opioid use disorder
- Development of medication for the treatment of respiratory depression due to opioid (prescribed or illicit) overdose/multidrug (polysubstance) overdose in a hospital or community setting.
- Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)
Research funding history
5 SBIR/STTR records share this UEI (2011–2013). Reported award amounts total $3,419,899. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services